Page Image

Lung Cancers Today

A new medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and more.

Mesothelioma
ICARUS-Lung01 Study Evaluates Datopotamab Deruxtecan in Advanced NSCLC
Datopotamab deruxtecan can improve survival in patients with advanced non-small cell lung cancer (NSCLC), specifically in those with non-squamous disease, according to results of the ICARUS-Lung01 study. Researchers in France investigated the efficacy and safety of the antibody-drug conjugate in a heavily pretreated population of patients. “Few treatments with limited benefit are currently available after failure of targeted therapies, immunotherapy and platinum-based chemotherapy in patients with advanced NSCLC,” the researchers said. ...
Advertisement
Advertisement

Expert Interviews on Lung Cancer

Conference Coverage

Knowledge Hubs

Mesothelioma
Advertisement
Advertisement